CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions - Quiz - MDSpire

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

  • By

  • Chu Xin Ng

  • Sakina Mustafa

  • Xin Yi Yap

  • Sau Har Lee

  • July 17, 2026

Share

Original Source(s)

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

  • by Chu Xin Ng, Sakina Mustafa, Xin Yi Yap, Sau Har Lee

  • July 17, 2026

Related Content

Results of applying the 9th edition TNM classification in the staging assessment of nasopharyngeal carcinoma: first data in Vietnam

Access to molecular diagnostics for CNS tumors through international outsourcing: experience from Jordan

The glucose-6-phosphatase system in cancer: from endoplasmic reticulum glucose-6-phosphate flux to stemness, immune escape, and therapeutic vulnerability